Cel Sci Corp SEC filings CVM

Cel Sci Corp has 1,007 filings in SEC EDGAR's recent list, going back to Jun 12, 2012. Its latest annual report, Form ARS, was filed on Jul 2, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 17, 2026 (shareholder vote results). The company's fiscal year ends on September 30.

Cel Sci Corp SEC filings
Form Description Filed Period
4 Insider transaction Oct 1, 2026 Sep 30, 2026
4 Insider transaction Oct 1, 2026 Sep 30, 2026
4 Insider transaction Oct 1, 2026 Sep 30, 2026
S-8 Employee stock plan registration Sep 3, 2026 —
4 Insider transaction Aug 26, 2026 Aug 25, 2026
4 Insider transaction Aug 17, 2026 Aug 14, 2026
4 Insider transaction Aug 17, 2026 Aug 14, 2026
4 Insider transaction Aug 17, 2026 Aug 14, 2026
4 Insider transaction Aug 17, 2026 Aug 14, 2026
4 Insider transaction Aug 17, 2026 Aug 14, 2026
4 Insider transaction Aug 17, 2026 Aug 14, 2026
8-K Current report
Shareholder vote results
Aug 17, 2026 Aug 14, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
ARS Annual report to shareholders Jul 2, 2026 Sep 30, 2025
DEF 14A Proxy statement Jul 2, 2026 Jun 23, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
8-K Current report
Material agreement, Other events
Jun 16, 2026 Jun 14, 2026
424B5 Prospectus supplement Jun 15, 2026 —
RW Form rw May 27, 2026 —
RW Form rw May 19, 2026 —
4 Insider transaction May 18, 2026 May 14, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Material agreement
May 14, 2026 May 11, 2026
4 Insider transaction May 14, 2026 May 13, 2026
8-K Current report
Material agreement, Other events
May 13, 2026 May 11, 2026
424B4 Prospectus May 13, 2026 —
EFFECT Filing May 11, 2026 —
CORRESP Letter to the SEC May 7, 2026 —
CORRESP Letter to the SEC May 7, 2026 —
CORRESP Letter to the SEC May 7, 2026 —
CORRESP Letter to the SEC May 7, 2026 —
CORRESP Letter to the SEC May 1, 2026 —
CORRESP Letter to the SEC May 1, 2026 —
CORRESP Letter to the SEC May 1, 2026 —
S-1/A Amended registration statement May 1, 2026 —
DEL AM Filing Apr 24, 2026 —
CORRESP Letter to the SEC Apr 20, 2026 —
S-1 Registration statement Apr 17, 2026 —
4 Insider transaction Apr 1, 2026 Mar 31, 2026
4 Insider transaction Apr 1, 2026 Mar 31, 2026
4 Insider transaction Apr 1, 2026 Mar 31, 2026
10-Q Quarterly report Feb 17, 2026 Dec 31, 2025
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
10-K Annual report Dec 29, 2025 Sep 30, 2025
4 Insider transaction Dec 5, 2025 Dec 4, 2025
EFFECT Filing Dec 3, 2025 —
CORRESP Letter to the SEC Dec 1, 2025 —
8-K Current report
Change to shareholder rights
Nov 24, 2025 Nov 18, 2025
S-3 Shelf registration Nov 7, 2025 —
8-K Current report
Change to shareholder rights
Nov 5, 2025 Oct 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
S-8 Employee stock plan registration Aug 29, 2025 —
8-K Current report
Material agreement, Other events
Aug 29, 2025 Aug 27, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 29, 2025 —
424B5 Prospectus supplement Aug 28, 2025 —
424B5 Prospectus supplement Aug 27, 2025 —
8-K Current report
Other events
Aug 25, 2025 Aug 22, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
EFFECT Filing Aug 12, 2025 —
CORRESP Letter to the SEC Aug 7, 2025 —
S-3/A Form s-3 Aug 5, 2025 —
CORRESP Letter to the SEC Aug 5, 2025 —
UPLOAD Letter from the SEC Jul 30, 2025 —
4 Insider transaction Jul 29, 2025 Jul 28, 2025
4 Insider transaction Jul 29, 2025 Jul 28, 2025
4 Insider transaction Jul 29, 2025 Jul 28, 2025
4 Insider transaction Jul 29, 2025 Jul 28, 2025
4 Insider transaction Jul 29, 2025 Jul 28, 2025
4 Insider transaction Jul 29, 2025 Jul 28, 2025
4 Insider transaction Jul 29, 2025 Jul 25, 2025
4 Insider transaction Jul 28, 2025 Jul 25, 2025
DRS Filing Jul 25, 2025 —
UPLOAD Letter from the SEC Jul 15, 2025 —
8-K Current report
Material agreement, Other events
Jul 14, 2025 Jul 11, 2025
424B5 Prospectus supplement Jul 14, 2025 —
S-3 Shelf registration Jul 3, 2025 —
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
8-K Current report
Material agreement, Other events
May 23, 2025 May 21, 2025
424B5 Prospectus supplement May 22, 2025 —
424B5 Prospectus supplement May 21, 2025 —
8-K Current report
Shareholder vote results
May 19, 2025 May 19, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
ARS Annual report to shareholders Apr 9, 2025 Mar 31, 2025
DEF 14A Proxy statement Apr 9, 2025 Mar 31, 2025
4 Insider transaction Apr 1, 2025 Mar 31, 2025
4 Insider transaction Apr 1, 2025 Mar 31, 2025
4 Insider transaction Apr 1, 2025 Mar 31, 2025
PRE 14A Preliminary proxy statement Mar 21, 2025 Mar 12, 2025
8-K Current report
Material agreement, Other events
Mar 18, 2025 Mar 17, 2025
424B5 Prospectus supplement Mar 18, 2025 —
UPLOAD Letter from the SEC Mar 12, 2025 —
CORRESP Letter to the SEC Mar 3, 2025 —
UPLOAD Letter from the SEC Feb 24, 2025 —
10-Q Quarterly report Feb 14, 2025 Dec 31, 2024
10-K Annual report Jan 13, 2025 Sep 30, 2024
424B3 Prospectus Jan 3, 2025 —
4 Insider transaction Jan 2, 2025 Dec 31, 2024
4 Insider transaction Jan 2, 2025 Dec 31, 2024
4 Insider transaction Jan 2, 2025 Dec 31, 2024
8-K Current report
Material agreement, Other events
Dec 31, 2024 Dec 29, 2024
424B5 Prospectus supplement Dec 30, 2024 —
NT 10-K Filing Dec 30, 2024 Sep 30, 2024
424B5 Prospectus supplement Dec 27, 2024 —
8-K Current report
Officer or director change
Nov 15, 2024 Nov 13, 2024
8-K Current report
Other events
Nov 13, 2024 Nov 12, 2024
EFFECT Filing Nov 7, 2024 —
CORRESP Letter to the SEC Nov 5, 2024 —
UPLOAD Letter from the SEC Nov 4, 2024 —
S-3/A Form s-3 Oct 30, 2024 —
S-3 Shelf registration Oct 25, 2024 —
POS AM Filing Oct 11, 2024 —
AW Filing Oct 10, 2024 —
S-3/A Filing Oct 8, 2024 —
4 Insider transaction Oct 1, 2024 Sep 30, 2024
4 Insider transaction Oct 1, 2024 Sep 30, 2024
4 Insider transaction Oct 1, 2024 Sep 30, 2024
8-K Current report
Other events
Sep 17, 2024 Sep 16, 2024
S-8 Employee stock plan registration Aug 30, 2024 —
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Material agreement, Other events
Jul 29, 2024 Jul 26, 2024
424B5 Prospectus supplement Jul 29, 2024 —
8-K Current report
Other events
Jul 26, 2024 Jul 26, 2024
4 Insider transaction Jul 1, 2024 Jun 28, 2024
4 Insider transaction Jul 1, 2024 Jun 28, 2024
4 Insider transaction Jul 1, 2024 Jun 28, 2024
8-K Current report
Regulation FD disclosure, Other events
Jun 20, 2024 Jun 18, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
4 Insider transaction May 10, 2024 May 8, 2024
4 Insider transaction May 9, 2024 May 8, 2024
4 Insider transaction May 9, 2024 May 8, 2024
3 Initial insider ownership Apr 23, 2024 Apr 19, 2024
4 Insider transaction Apr 23, 2024 Apr 19, 2024
4 Insider transaction Apr 23, 2024 Apr 19, 2024
4 Insider transaction Apr 23, 2024 Apr 19, 2024
4 Insider transaction Apr 23, 2024 Apr 19, 2024
4 Insider transaction Apr 23, 2024 Apr 19, 2024
8-K Current report
Officer or director change
Apr 23, 2024 Apr 19, 2024
8-K Current report
Shareholder vote results
Apr 19, 2024 Apr 19, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
DEFA14A Additional proxy material Mar 7, 2024 —
ARS Annual report to shareholders Mar 7, 2024 Dec 31, 2023
DEF 14A Proxy statement Mar 7, 2024 Mar 1, 2024
10-Q Quarterly report Feb 14, 2024 Dec 31, 2023
8-K Current report
Material agreement, Other events
Feb 13, 2024 Feb 8, 2024
424B5 Prospectus supplement Feb 9, 2024 —
4 Insider transaction Jan 2, 2024 Dec 29, 2023
4 Insider transaction Jan 2, 2024 Dec 29, 2023
4 Insider transaction Jan 2, 2024 Dec 29, 2023
S-8 Employee stock plan registration Dec 22, 2023 —
10-K Annual report Dec 21, 2023 Sep 30, 2023
8-K Current report
Material agreement, Other events
Nov 20, 2023 Nov 15, 2023
424B5 Prospectus supplement Nov 16, 2023 —
8-K Current report
Material agreement, Officer or director change, Other events
Oct 30, 2023 Oct 26, 2023
8-K Current report
Other events
Oct 24, 2023 Oct 23, 2023
4 Insider transaction Oct 3, 2023 Sep 29, 2023
4 Insider transaction Oct 3, 2023 Sep 29, 2023
4 Insider transaction Oct 3, 2023 Sep 29, 2023
8-K Current report
Material agreement, Officer or director change
Aug 31, 2023 Aug 28, 2023
4 Insider transaction Aug 10, 2023 Aug 8, 2023
4 Insider transaction Aug 10, 2023 Aug 8, 2023
4 Insider transaction Aug 10, 2023 Aug 8, 2023
4 Insider transaction Aug 10, 2023 Aug 8, 2023
4 Insider transaction Aug 10, 2023 Aug 8, 2023
4 Insider transaction Aug 10, 2023 Aug 8, 2023
4 Insider transaction Aug 10, 2023 Aug 8, 2023
4 Insider transaction Aug 10, 2023 Aug 8, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Other events
Jul 20, 2023 Jul 20, 2023
424B5 Prospectus supplement Jul 18, 2023 —
8-K Current report
Material agreement, Other events
Jul 18, 2023 Jul 17, 2023
FWP Free writing prospectus Jul 17, 2023 —
424B5 Prospectus supplement Jul 17, 2023 —
8-K Current report
Other events
Jul 14, 2023 Jul 14, 2023
8-K Current report
Other events
Jul 12, 2023 Jul 11, 2023
4 Insider transaction Jul 3, 2023 Jun 30, 2023
4 Insider transaction Jul 3, 2023 Jun 30, 2023
4 Insider transaction Jul 3, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results
May 23, 2023 May 23, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
8-K Current report
Other events
May 2, 2023 May 2, 2023
8-K Current report
Material agreement, Other events
May 1, 2023 Apr 27, 2023
424B5 Prospectus supplement May 1, 2023 —
8-K Current report
Other events
Apr 19, 2023 Apr 19, 2023
DEFA14A Additional proxy material Apr 10, 2023 —
ARS Annual report to shareholders Apr 10, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 10, 2023 May 23, 2023
4 Insider transaction Apr 6, 2023 Mar 31, 2023
4 Insider transaction Apr 6, 2023 Mar 31, 2023
4 Insider transaction Apr 6, 2023 Mar 31, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
CVM (NYSE)
Fiscal year ends
September 30
Incorporated in
CO
Headquarters
Vienna, VA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
725363

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.